GlycoMimetics
GLYC
$1.64
Share price
-4.09%
Change (1 day)
19.71%
Change (1 year)
Categories
Operating Margin for GlycoMimetics (GLYC)
Operating Margin as of April 2024 (TTM): -34,735.80%
According to GlycoMimetics 's latest financial reports and stock price the company's current Operating Margin is -34,735.80%. At the end of 2021 the company had an Operating Margin of -5,470.69%.
Operating Margin history for GlycoMimetics from 2013 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -5,470.69% | 979.38% |
| 2020 | -506.83% | |
| 2016 | -172,504.43% | 270721.12% |
| 2015 | -63.70% | -14.08% |
| 2014 | -74.13% | -72.05% |
| 2013 | -265.21% | -1205.06% |
| 2012 | 24.00% | -115.04% |
| 2011 | -159.54% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | -100.07% | 🇺🇸 USA |
 Pfizer PFE | 34.61% | -100.10% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -100.05% | 🇫🇷 France |
 Palatin Technologies PTN | -2,465.05% | -92.90% | 🇺🇸 USA |
 bluebird bio
BLUE | -7,407.86% | -78.67% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.